Showing results (21-30 of 44) with videos related to
Sort By:
Pageof 5
No to Shinkei = Brain and Nerve|July 22, 2006
[Cluster like headache in a patient with the Maffucci's syndrome]Eiji Kitamura, Noboru Imai, Takashi Konisi, et al.Neuromuscular Disorders : NMD|March 10, 2009
Relapse of polyneuropathy, organomegaly, endocrinopathy, M-protein, and skin changes (POEMS) syndrome without increased level of vascular endothelial growth factor following successful autologous peripheral blood stem cell transplantationNoboru Imai, Jun Taguchi, Nobuyasu Yagi, et al.Internal Medicine (Tokyo, Japan)|April 17, 2012
Increase of serum vascular endothelial growth factors in wet beriberi: two case reportsNoboru Imai, Mai Kubota, Mayu Saitou, et al.Scientific Reports|September 18, 2024
Efficacy of galcanezumab in migraine central sensitizationDaisuke Danno, Noboru Imai, Shigekazu Kitamura, et al.Cephalalgia : an International Journal of Headache|February 1, 2011
Clinical profile of cluster headaches in Japan: low prevalence of chronic cluster headache, and uncoupling of sense and behaviour of restlessnessNoboru Imai, Nobuyasu Yagi, Ryou Kuroda, et al.Neurology and Therapy|September 11, 2023
Effects of Fremanezumab on Medication Overuse in Japanese Chronic Migraine Patients: Post Hoc Analysis of a Multicenter, Randomized, Double-Blind, Placebo-Controlled TrialNoboru Imai, Yuki Isogai, Yoshiyuki Shibasaki, et al.Internal Medicine (Tokyo, Japan)|February 3, 2007
Efficacy of autologous peripheral blood stem cell transplantation in POEMS syndrome with polyneuropathyNoboru Imai, Eiji Kitamura, Takayoshi Tachibana, et al.[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|May 14, 2011
[POEMS syndrome diagnosed by detection of M-protein on immunofixation and increased level of vascular endothelial growth factor]Yukako Hattori, Jun Taguchi, Noboru Imai, et al.[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|January 16, 2013
[POEMS syndrome treated with lenalidomide plus high-dose dexamethasone as a pre-transplant induction therapy]Shiro Matsuura, Eriko Ogusa, Jun Taguchi, et al.The Journal of Headache and Pain|March 12, 2025
Efficacy and continuability of 675 mg fremanezumab administration over 2 yearsShohei Yoshida, Noboru Imai, Masato Keicho, et al.Pageof 5